Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose serves as a source of calories and water for hydration, and is metabolized to carbon dioxide and water, yielding energy. Potassium chloride provides potassium ions to maintain electrolyte balance, necessary for nerve conduction, muscle contraction, and acid-base regulation. The combination replenishes fluid and electrolytes in patients with hypokalemia and dehydration.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion of 1000-2000 mL/day (providing 50-100 g dextrose and 1.5-3 g potassium chloride) at a rate of 50-100 mL/hour; adjust based on fluid and electrolyte requirements.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose: not applicable (rapidly metabolized). Potassium: distribution half-life ~1 h, terminal half-life ~8 h (in patients with normal renal function); prolonged in renal impairment.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Potassium: >90% renal (glomerular filtration and tubular secretion). Dextrose: metabolized to CO2 and water; negligible renal excretion (<5%).
Category C
Category C
IV Fluid
IV Fluid